| Literature DB >> 33277261 |
Hanieh Safari1, Nicholas Kaczorowski1, Michael L Felder1, Emma R Brannon1, Mita Varghese2, Kanakadurga Singer2, Omolola Eniola-Adefeso3.
Abstract
Bile acids are proposed as therapeutic agents for various diseases, including liver diseases and obesity. However, oral or subcutaneous administration of a solubilized version of these drugs has limited efficacy and imposes unwanted side effects. Here, we describe a gold-templating method for fabricating stable, bile salt-cholate or deoxycholate-microparticles. The gold ions' reduction at the oil-water interface in a double emulsion solvent evaporation process enables a gold-bile salt interaction and the formation of bile salt particles. We demonstrate that composite microparticles release cholate/deoxycholate into solution via a surface erosion process. We illustrate these particles' capability to lyse adipocytes, both in vitro and in vivo, with minimal side effects, contrary to the Food and Drug Administration-approved salt solution that leads to severe inflammation and ulceration. Overall, particle-based cholate/deoxycholate opens opportunities for localized delivery of these salts, improving efficacy while minimizing side effects associated with oral and subcutaneous use.Entities:
Year: 2020 PMID: 33277261 PMCID: PMC7821899 DOI: 10.1126/sciadv.abd8019
Source DB: PubMed Journal: Sci Adv ISSN: 2375-2548 Impact factor: 14.136